ALG13-Related Epilepsy: Current Insights and Future Research Directions
Neurochemical Research · 2025
DOI: 10.1007/s11064-024-04300-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemical Research, 2025. Verfasst von Peng Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, 750004, China. Hauptthemen laut MEDLINE: Epilepsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Key R&D projects of Ningxia Hui Autonomous Region, Scientific Research Program of Ningxia Colleges and Universities.
Abstract (Originalsprache)
The ALG13 gene encodes a subunit of the uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) transferase enzyme, which plays a key role in the N-linked glycosylation pathway. This pathway involves the attachment of carbohydrate structures to asparagine (Asn) residues in proteins within the endoplasmic reticulum, by which N-glycosylated proteins produced participate a wide range of processes such as electrical gradients formation and neurotransmission. Mutations in the ALG13 gene have been identified as a causative factor for congenital disorders of glycosylation (CDG) and have been frequently associated with epilepsy in affected individuals. Several studies have demonstrated a strong correlation between abnormal N-glycosylation due to ALG13 deficiency and the onset of epilepsy. Despite these findings, the precise role of ALG13 in the pathogenesis of epilepsy remains unclear. This review provides a comprehensive overview of the current literature on ALG13-related disorders, with a focus on recent evidence regarding its role in epilepsy development and progression. Future research directions are also proposed to further elucidate the molecular mechanisms underlying this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, 750004, China.
- Ningxia Key Laboratory of Cerebrocranial Diseases, The Incubation Base of National Key Laboratory, Ningxia Medical University, Yinchuan, Ningxia Province, 750004, China.
- General Hospital of Ningxia Medical University, No. 804 of Shengli Street, Yinchuan, Ningxia Province, 750004, China.
- Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, 750004, China. zhang_jing8523@126.com.
- Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, 750004, China. zhang_jing8523@126.com.
Förderung
- National Natural Science Foundation of China (NSFC)
- Key R&D projects of Ningxia Hui Autonomous Region
- Scientific Research Program of Ningxia Colleges and Universities
Zitieren
APA
Gao, P., Chen, H., Sun, Y., Qian, X., Sun, T., Fan, Y., & Zhang, J. (2025). ALG13-Related Epilepsy: Current Insights and Future Research Directions. Neurochemical Research. https://doi.org/10.1007/s11064-024-04300-y
Vancouver
Gao P, Chen H, Sun Y, Qian X, Sun T, Fan Y, et al. ALG13-Related Epilepsy: Current Insights and Future Research Directions. Neurochemical Research. 2025. doi:10.1007/s11064-024-04300-y
BibTeX
@article{Gao2025,
author = {Gao, Peng and Chen, Haoran and Sun, Yangyang and Qian, Xin and Sun, Tao and Fan, Yuhan and Zhang, Jing},
title = {ALG13-Related Epilepsy: Current Insights and Future Research Directions},
journal = {Neurochemical Research},
year = {2025},
doi = {10.1007/s11064-024-04300-y}
}
EUVIMED